Volume 11, Issue 1 (Feb 2023)
Res Mol Med (RMM) 2023, 11(1): 67-72 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahimzadeh G, Sarli S, Ahanjan M. Prevalence of β-lactamase-encoding Genes in Isolated Acinetobacter baumannii From Clinical Samples in Sari, Iran. Res Mol Med (RMM) 2023; 11 (1) :67-72
URL: http://rmm.mazums.ac.ir/article-1-511-en.html
URL: http://rmm.mazums.ac.ir/article-1-511-en.html
1- Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
2- Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
3- Department of Microbiology, Molecular and Cellular Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. ,ahanjan2007@gmail.com
2- Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
3- Department of Microbiology, Molecular and Cellular Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. ,
Abstract: (1435 Views)
Background: The prevalence of Acinetobacter baumannii as a causative agent of hospital-acquired infections, particularly in burn units and intensive care units, is a major concern due to its innate and acquired resistance to several antibiotics. The presence of beta-lactamase-encoding genes in this bacterium has made it resistant to carbapenems as the last-resort antibiotics for treating infections caused by A. baumannii. This study aims to determine the prevalence of β-lactamase-encoding genes and antibiotic resistance of A. baumannii isolates from burn patients in northern Iran.
Methods: In this descriptive cross-sectional study, A. baumannii isolates were obtained from clinical samples of patients in Zare Burn Hospital in Sari City, from 2013 to 2015. The isolates’ antibiotic sensitivity was determined using the disk diffusion method. To investigate the prevalence of β-lactamase genes (blaVIM, blaIMP, and INT), the PCR test was conducted.
Results: Of 150 patients, 54.7% were men and 45.3% were women. The highest resistance rateswere against ceftazidime, cefepime, meropenem, imipenem, ciprofloxacin, amikacin, gentamicin, and colistin in order. It was observed that 31% of the isolates produced metallo-β-lactamase enzyme. The
genes blaVIM, blaIMP, and INT were detected in 35%, 45%, and 60% of the isolates, respectively.
Conclusion: A. baumannii isolates have significant resistance to cephalosporins and carbapenems. It is recommended to avoid the irrational prescription of cephalosporins and carbapenems for infections
caused by A. baumannii.
Results: Of 150 patients, 54.7% were men and 45.3% were women. The highest resistance rateswere against ceftazidime, cefepime, meropenem, imipenem, ciprofloxacin, amikacin, gentamicin, and colistin in order. It was observed that 31% of the isolates produced metallo-β-lactamase enzyme. The
genes blaVIM, blaIMP, and INT were detected in 35%, 45%, and 60% of the isolates, respectively.
Conclusion: A. baumannii isolates have significant resistance to cephalosporins and carbapenems. It is recommended to avoid the irrational prescription of cephalosporins and carbapenems for infections
caused by A. baumannii.
Keywords: Nosocomial infection, Multiple drug resistance (MDR), β-lactamase, Metallobetalactamase, Acinetobacter baumannii
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
